Alzheimer's, Parkinson's, and various neurodegenerative diseases are generally characterized by neuronal loss, which directly induces cognitive and motor dysfunctions. Secondary metabolites, as natural products of aromatic and medicinal plants and other origins, could present a promising alternative source to combat neurodegenerative diseases. With their important phytochemical composition, especially in alkaloids, terpenes, flavonoids, and polyphenols, these secondary metabolites pave the way for the development of new therapies. Their neuroprotective properties and their antioxidant and anti-inflammatory activities constitute a solid basis for their use in the fight against neurodegenerative diseases. This chapter aims to explore the therapeutic effects of secondary metabolites in the fight against neurodegenerative diseases while discussing the responsible mechanisms, challenges, perspectives, as well as the limits of this application.
Chitosan and its derivatives have garnered increasing interest in oncology due to their unique properties, such as biocompatibility, bioactivity and their ability to interact with molecules. These characteristics make them promising candidates for the development of novel anticancer therapies. Chitosan can be employed as drug delivery systems, enhancing the availability and targeted release of therapeutic agents into cancer cells. Additionally, they have demonstrated the ability to inhibit cell proliferation, induce apoptosis, and modulate immune responses, positioning them as multifunctional tools in the fight against cancer. Recent research has focused on the development of chitosan-based nanoparticles for targeted drug delivery in chemotherapy, reducing side effects on healthy cells. Furthermore, Chitosan systems have been used to deliver siRNA and other therapeutic molecules, inhibiting tumor growth at the genetic level. These advancements highlight chitosan's potential in developing more effective and less toxic cancer treatments.
The application of biomaterials in the biomedical field represents a major advancement, offering effective and sustainable alternative solutions. These materials stand out for their unique properties, particularly their biocompatibility and biodegradability. However, the choice between animal or non-animal sources constitutes a primary challenge, directly influencing their use and effectiveness in various contexts. This chapter offers a comparative analysis of biomaterials of animal and non-animal origin, highlighting their distinct properties and adaptability to biomedical applications, while mentioning the limitations of each type of source. This multidimensional analysis thus provides a critical framework for guiding the choice of biomaterials based on the specific needs of biomedical applications and opens up perspectives on the development of hybrid or alternative materials capable of overcoming these limitations.
Biomaterials have attracted growing interest in the biomedical field thanks to their unique ability to interact with biological systems and make a significant contribution to advances in medicine, tissue engineering and sustainable technologies. Their importance lies in their dual potential: improving patients' quality of life while reducing their impact on the environment. This chapter first presents a detailed classification of biomaterials, distinguishing between natural, synthetic and hybrid categories. Next, the key properties of biomaterials are explored, showing their role in biocompatibility, durability and clinical performance. These fundamental characteristics directly influence the choice of biomaterials for a variety of applications. In addition, this chapter highlights the diversity of current biomaterial applications, while discussing the persistent challenges and limitations encountered in their design and use. Finally, future prospects are discussed, including the emergence of personalized biomaterials, which could revolutionize biomedical technologies.
Osteoporosis is a common degenerative disease in postmenopausal women, characterized by a loss of bone density and skeletal fragility, increasing fracture risk. This chapter examines the use of chitosan, a natural biopolymer derived from chitin, as a therapeutic agent in osteoporosis treatment. Chitosan's unique properties, such as biocompatibility, biodegradability, and the ability to form three-dimensional structures, make it a promising candidate for bone therapies. The chapter also analyzes chemical and functional modifications to chitosan that enhance its bioactive effects and drug delivery capabilities, offering promising perspectives for non-hormonal osteoporosis treatments.